FindTrial
Sign In

Observational Study on Ferroptosis-related gene as New Prognostic Markers in Acute Myeloid Leukemia

Observational Study on Ferroptosis-related gene as New Prognostic Markers in Acute Myeloid Leukemia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074896
Enrollment
Unknown
Registered
2023-08-18
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myelogenous leukemia

Interventions

AMl group:N/A
Healthy control group:N/A

Sponsors

Zhejiang Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: 1: Patients who meet the diagnostic criteria for AML 2: Did not participate in other clinical studies

Exclusion criteria

Exclusion criteria: 1: Excluding other diseases with abnormal proliferation of original cells, including myelodysplastic syndrome, chronic leukemia, etc. Heterozygous and mixed leukemia 2: Patients with severe heart, brain, liver, kidney disease and mental illness 3: Eastern Cooperative Oncology Group (ECOG) score >2 4: Patients who refuse follow-up 5: It was found that there were any circumstances that were not suitable for inclusion in the study

Design outcomes

Primary

MeasureTime frame
Expression of ferroptosis Related Genes;—

Secondary

MeasureTime frame
effectiveness;Bone marrow routine;Bone marrow biopsy;—

Countries

China

Contacts

Public ContactWu Dijiong

Zhejiang Provincial Hospital of Traditional Chinese Medicine

wdj850@163.com+86 571 8707 3569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026